Risks of Bladder Cancer
People with Type 2 diabetes may be prescribed Actos®—also known as pioglitazone—which is a prescription medication designed to control blood glucose levels and manage symptoms of the disease. Although Actos can be effective at controlling Type 2 diabetes, the drug has been linked to serious and even fatal health problems, including bladder cancer.
If you or someone you love took Actos and was diagnosed with bladder cancer while taking the medication or after treatment, you may be eligible for compensation for your medical bills and other injury-related expenses. Call the Actos lawyers at Ferrer, Poirot & Wansbrough today at (800) 210-8503 or fill out a free initial consultation form.
Bladder Cancer Treatments
In 2011, the U.S. Food and Drug Administration issued a report linking Actos to the development of bladder cancer in people who take the medication. People with bladder cancer often need expensive and invasive treatments, such as:
Patients with bladder cancer may develop tumors in or around the bladder, which often have to be surgically removed. Follow-up surgeries may be required to remove additional tumors.
- Radiation and Chemotherapy
Some bladder cancer patients may require radiation or chemotherapy to treat the disease and prevent it from returning. These treatments can be expensive and may interfere with patients’ ability to work.
Advanced stages of bladder cancer may require the removal of part of or the entire bladder. This requires additional surgeries to create an artificial bladder.
Ferrer, Poirot & Wansbrough Can Help
When you’ve been injured, turn to us. For more than 35 years, Ferrer, Poirot & Wansbrough has been helping people who were injured by prescription medications. Now, it’s our turn to help you. Call our Actos injury lawyers, and let us fight for your rights to the money you deserve.
Actos® is a registered trademark of Takeda Pharmaceutical Company Limited.
This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration or Takeda Pharmaceutical Company Limited.